ARS Pharmaceuticals (SPRY) Change in Inventory (2024 - 2026)

ARS Pharmaceuticals has reported Change in Inventory for 3 years, with the latest figure at $294000.0 in Q1 2026.

• Quarterly Change in Inventory fell 96.52% year-over-year to $294000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.8 million (down 3.91% YoY) and the FY2025 annual result came in at $22.0 million, up 269.82% from the prior year.
• Change in Inventory fell to $294000.0 in Q1 2026 per SPRY's latest filing, from $9.7 million in the prior quarter.
• Over five years, Change in Inventory peaked at $9.7 million in Q4 2025 and troughed at -$963000.0 in Q3 2025.
• A 3-year average of $4.0 million and a median of $4.8 million in 2025 frame the typical range for Change in Inventory.
• The widest YoY moves for Change in Inventory: up 68.64% in 2025, down 626.23% in 2025.
• Over 3 years, Change in Inventory stood at $5.8 million in 2024, then jumped by 68.64% to $9.7 million in 2025, then slumped by 96.97% to $294000.0 in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered $294000.0, $9.7 million, and -$963000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.